We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHXM
12501
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$49K ﹤0.01%
2,071
-486
-19% -$16.4K
QTT
12502
CALL
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$49K ﹤0.01%
+17,500
New +$131K
ANIX icon
12503
CALL
Anixa Biosciences
ANIX
$122M
$48K ﹤0.01%
16,300
+3,200
+24% +$12.9K
BIVI icon
12504
BioVie
BIVI
$18.5M
$48K ﹤0.01%
+106
New +$61.2K
CYCN icon
12505
Cyclerion Therapeutics
CYCN
$18.7M
$48K ﹤0.01%
1,396
-1,370
-50% -$64.7K
DMAC icon
12506
CALL
DiaMedica Therapeutics
DMAC
$364M
$48K ﹤0.01%
+12,800
New +$50.3K
FOA icon
12507
CALL
Finance of America Companies
FOA
$169M
$48K ﹤0.01%
1,210
-6,920
-85% -$328K
GCTK icon
12508
GlucoTrack
GCTK
$3.03M
$48K ﹤0.01%
+2
New +$46.5K
DMRA
12509
Damora Therapeutics
DMRA
$1.89B
$48K ﹤0.01%
+639
New +$50.2K
MREO
12510
PUT
Mereo BioPharma
MREO
$43.4M
$48K ﹤0.01%
29,700
-60,000
-67% -$120K
USIO icon
12511
CALL
Usio Inc
USIO
$77.2M
$48K ﹤0.01%
11,000
-15,800
-59% -$95.1K
YRD
12512
Yiren Digital
YRD
$94.5M
$48K ﹤0.01%
+16,851
New +$54K
TECX
12513
CALL
Tectonic Therapeutic
TECX
$717M
$48K ﹤0.01%
+1,042
New +$59.9K
KA
12514
DELISTED
Kineta, Inc. Common Stock
KA
$48K ﹤0.01%
2,311
-3,602
-61% -$156K
ROI
12515
DELISTED
RiskOn International, Inc. Common Stock
ROI
$48K ﹤0.01%
+718
New +$76.2K
WTT
12516
DELISTED
Wireless Telecom Group, Inc.
WTT
$48K ﹤0.01%
+21,762
New +$43.9K
TCRR
12517
PUT
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$48K ﹤0.01%
10,300
-86,400
-89% -$540K
NBEV
12518
PUT
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$48K ﹤0.01%
46,500
-67,800
-59% -$89.5K
GASS icon
12519
StealthGas
GASS
$353M
$47K ﹤0.01%
22,189
-16,876
-43% -$42.8K
HEPA
12520
PUT
DELISTED
Hepion Pharmaceuticals
HEPA
$47K ﹤0.01%
41
-155
-79% -$212K
MDWD icon
12521
PUT
MediWound
MDWD
$171M
$47K ﹤0.01%
+2,829
New +$58.8K
MYSZ icon
12522
My Size
MYSZ
$1.75M
$47K ﹤0.01%
+58
New +$89K
YRD
12523
CALL
Yiren Digital
YRD
$94.5M
$47K ﹤0.01%
16,600
-3,100
-16% -$9.94K
ASPCW
12524
DELISTED
Alpha Capital Acquisition Co Warrant
ASPCW
$47K ﹤0.01%
+55,020
New +$39.4K
DNTH icon
12525
Dianthus Therapeutics
DNTH
$6.24B
$46K ﹤0.01%
+652
New +$65.5K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.